LTGR
LTGRCIK 0002104177
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade LTGR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
LTGR SPAC files S-1/A for $150M IPO at $10.00 per unit, with $1.9M net proceeds to company
7 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Aug 12, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statement of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Six months ended June 30, 2026 |
|---|---|---|
| General and administrative costs | 278,000 | 321,000 |
| Advisory fee expense | 5,175,000 | 5,175,000 |
| Loss from operations | (5,453,000) | (5,496,000) |
| Other income | ||
| Interest income on investment held in Trust Account | 387,000 | 387,000 |
| Interest income on cash in operating account | 3,000 | 4,000 |
| Total other income | 390,000 | 391,000 |
| Net loss | (5,063,000) | (5,105,000) |
| Weighted average Class A ordinary shares outstanding basic and diluted | 4,739,000 | 2,396,000 |
| Class A ordinary shares basic and diluted net loss per share | (0.51) | (0.68) |
| Weighted average Class B ordinary shares outstanding - | ||
| Basic and diluted | 5,206,000 | 5,104,000 |
| Class B ordinary shares Basic and diluted net loss per share | (0.51) | (0.68) |
Condensed Balance Sheet (Unaudited)
| Description | June 30, 2026 (unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash | 1,625,000 | 50,000 |
| Prepaid expenses | 179,000 | — |
| Deferred offering costs | — | 108,000 |
| Total current assets | 1,804,000 | 158,000 |
| Held in Trust Account | 173,749,000 | — |
| Total assets | 175,553,000 | 158,000 |
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | 25,000 | 10,000 |
| Accrued expenses | 106,000 | 20,000 |
| Accrued offering costs | — | 83,000 |
| Deferred compensation related parties | 30,000 | — |
| Promissory note related party | — | 50,000 |
| Total current liabilities | 161,000 | 163,000 |
| Deferred underwriting payable | 5,175,000 | — |
| Advisory fee payable | 5,175,000 | — |
| Total liabilities | 10,511,000 | 163,000 |
| Commitments and Contingencies | ||
| Class A ordinary shares subject to possible redemption, 17,250,000 shares at redemption value of $10.07 per share | 173,749,000 | — |
| Shareholders’ Deficit | ||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding | — | — |
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued or outstanding (excluding 17,250,000 shares subject to possible redemption) | — | — |
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding(1) | 1,000 | 1,000 |
| Additional paid-in capital | 24,000 | |
| Accumulated deficit | (8,708,000) | (30,000) |
| Total shareholders’ deficit | (8,707,000) | (5,000) |
| Total liabilities and shareholders’ deficit | 175,553,000 | 158,000 |
Condensed Statement of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 |
|---|---|
| Net loss | (5,105,000) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Income earned on Trust Account | (387,000) |
| Changes in operating assets and liabilities: | |
| (Increase) in prepaid expenses and other | (179,000) |
| Increase in accounts payable | 15,000 |
| Increase in accrued expenses | 86,000 |
| Increase in deferred compensation related parties | 30,000 |
| Increase in deferred advisory fee | 5,175,000 |
| Net cash used in operating activities | (365,000) |
| Cash flows from investing activities | |
| Investment of cash into Trust Account | (173,363,000) |
| Cash used in investing activities | (173,363,000) |
| Cash flows from financing activities | |
| Proceeds from Sponsor Note | 199,000 |
| Repayment Sponsor Note | (269,000) |
| Proceeds from sale of units net of underwriting discounts and reimbursements | 172,500,000 |
| Proceeds from sale of Private Placement Warrants | 3,600,000 |
| Payment of offering costs | (727,000) |
| Net cash provided by financing activities | 175,303,000 |
| Net increase in cash | 1,575,000 |
| Cash beginning of period | 50,000 |
| Cash end of period | 1,625,000 |
| Supplemental disclosure of noncash activities: | |
| Deferred underwriting payable | 5,175,000 |
| Deferred advisory fee payable | 5,175,000 |
| Deferred offering costs and general and administrative costs paid directly by Sponsor through promissory note-related party | 20,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗